Dr. Shishuka Malhotra

Psychiatry
4825 Higbee Ave Nw, Suite 120, 
Canton, OH 
4825 Higbee Ave Nw, Suite 120, 
Canton, OH 

Overview

Shishuka Malhotra is a Psychiatrist in Canton, Ohio. Her top areas of expertise are Alzheimer's Disease and Dementia.

Her clinical research consists of co-authoring 2 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Psychiatry

Licenses

Psychiatry & Neurology in OH

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
SummaCare
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

4825 Higbee Ave Nw, Suite 120, Canton, OH 44718

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, 76-week Study Evaluating the Safety and Efficacy of Two Doses of Simufilam in Subjects With Mild-to-Moderate Alzheimer's Disease
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, 76-week Study Evaluating the Safety and Efficacy of Two Doses of Simufilam in Subjects With Mild-to-Moderate Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: September 22, 2025
Intervention Type: Drug
Study Drug: Simufilam
Study Phase: Phase 3
A 12-Month, Open-Label Safety Study of Simufilam Followed by a 6-Month Randomized Withdrawal and 6 Additional Months Open-Label in Mild-to-moderate Alzheimer's Disease Patients
A 12-Month, Open-Label Safety Study of Simufilam Followed by a 6-Month Randomized Withdrawal and 6 Additional Months Open-Label in Mild-to-moderate Alzheimer's Disease Patients
Enrollment Status: Completed
Publish Date: April 22, 2025
Intervention Type: Drug
Study Drug: Simufilam
Study Phase: Phase 2
A Randomized, Placebo-Controlled, Double-Blind Study of ATH-1017 Treatment in Subjects With Mild to Moderate Alzheimer's Disease
A Randomized, Placebo-Controlled, Double-Blind Study of ATH-1017 Treatment in Subjects With Mild to Moderate Alzheimer's Disease
Enrollment Status: Completed
Publish Date: April 04, 2025
Intervention Type: Drug
Study Drug: ATH-1017
Study Phase: Phase 2/Phase 3
A Phase 1 Placebo-Controlled, Single- and Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous ACU193 in Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease
A Phase 1 Placebo-Controlled, Single- and Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous ACU193 in Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease
Enrollment Status: Completed
Publish Date: July 19, 2023
Intervention Type: Drug
Study Drug: ACU193
Study Phase: Phase 1
A Phase IIIb Multi-Center, Open-Label, Mirror-Image, Trial in Adult Subjects With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®
A Phase IIIb Multi-Center, Open-Label, Mirror-Image, Trial in Adult Subjects With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®
Enrollment Status: Terminated
Publish Date: September 05, 2021
Intervention Type: Combination product
Study Drug: ABILIFY MYCITE
Study Phase: Phase 3
A Multicenter, Dose-Optimized, Open-Label Safety Study With KP415 in Children With Attention-Deficit/Hyperactivity Disorder
A Multicenter, Dose-Optimized, Open-Label Safety Study With KP415 in Children With Attention-Deficit/Hyperactivity Disorder
Enrollment Status: Completed
Publish Date: July 19, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

2 Total Publications

Safety and Efficacy of the NMDA-2b-Selective Negative Allosteric Modulator BI 1569912: A Phase Ib Randomized Trial in Major Depressive Disorder.
Safety and Efficacy of the NMDA-2b-Selective Negative Allosteric Modulator BI 1569912: A Phase Ib Randomized Trial in Major Depressive Disorder.
Journal: Clinical pharmacology and therapeutics
Published: February 13, 2025
Similar Doctors
Expertise in
9
conditions
Dr. Brian S. Appleby
Psychiatry | Geriatrics
Expertise in
9
conditions
Dr. Brian S. Appleby
Psychiatry | Geriatrics

University Hospitals Medical Group Inc

11100 Euclid Ave, 
Cleveland, OH 
 (46.3 miles away)
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients

Brian Appleby is a Psychiatrist and a Geriatrics provider in Cleveland, Ohio. Dr. Appleby is highly rated in 9 conditions, according to our data. His top areas of expertise are Dementia, Kuru, Alzheimer's Disease, and Cerebellar Degeneration. Dr. Appleby is currently accepting new patients.

Expertise in
3
conditions
Dr. Joseph R. Calabrese
Psychiatry
Expertise in
3
conditions
Dr. Joseph R. Calabrese
Psychiatry
11100 Euclid Ave, 
Cleveland, OH 
 (46.3 miles away)
216-844-2400
Languages Spoken:
English
See accepted insurances

Joseph Calabrese is a Psychiatrist in Cleveland, Ohio. Dr. Calabrese is highly rated in 3 conditions, according to our data. His top areas of expertise are Bipolar Disorder (BPD), Post-Traumatic Stress Disorder (PTSD), Major Depression, Generalized Anxiety Disorder (GAD), and Deep Brain Stimulation.

Expertise in
7
conditions
Dr. Ranga Thalluri
Psychiatry
Expertise in
7
conditions
Dr. Ranga Thalluri
Psychiatry

Aultman Alliance Community Hospital

200 E State St, 
Alliance, OH 
 (17.4 miles away)
330-596-7650
Languages Spoken:
English
See accepted insurances

Ranga Thalluri is a Psychiatrist in Alliance, Ohio. Dr. Thalluri is highly rated in 7 conditions, according to our data. His top areas of expertise are Seasonal Affective Disorder (SAD), Major Depression, Schizoaffective Disorder, and Dementia.

Frequently Asked Questions about Dr. Shishuka Malhotra

How do I make an appointment with Dr. Shishuka Malhotra?

You can book an appointment with Dr. Shishuka Malhotra by calling their office at 330-493-1247. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Shishuka Malhotra a top-rated expert for Alzheimer's Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Shishuka Malhotra is classified as an Experienced expert for Alzheimer's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Shishuka Malhotra specialize in?

While Dr. Shishuka Malhotra is a Psychiatry, they have specific expertise in Alzheimer's Disease, Dementia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Psychiatry.

Does Dr. Shishuka Malhotra participate in research or clinical trials?

Yes. Dr. Shishuka Malhotra has published 2 articles and abstracts on conditions like Alzheimer's Disease. You can view a list of Dr. Shishuka Malhotra's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Shishuka Malhotra accept my insurance?

Dr. Shishuka Malhotra accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 330-493-1247 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Malhotra's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile